CB vs PRLD · P/E 14, rev $59.40B vs rev $6.5M
Chubb Ltd (CB) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Chubb Ltd (CB) is a insurance - property & casualty company listed on US.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
Latest reported CB revenue for 2025-12-31 was $59.40B. Net income was $10.31B. Revenue was up 6.5% from 2024-12-31 to 2025-12-31. CB currently screens at market cap $114.26B and trailing P/E 13.7.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
CB currently screens at market cap $114.26B and trailing P/E 13.7. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the CB and PRLD stock pages for the full models.
Not investment advice.